Announcements Trials
Browse Landscape

Phase

Phase 3 5

Status

Completed 5Unknown 1Terminated 1

Sponsor Class

OTHER 2NIH 2NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 5Neoplasm Metastasis 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 165Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 83Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Ovariectomy × Clear all
NCT00066690 2026-02-06

SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed
3,066 enrolled 15 charts
Breast

Breast Neoplasms

NCT00293540 2016-07-27

Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer

International Breast Cancer Research Foundation

Phase 3 Completed
249 enrolled 9 charts
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00201851 2015-04-29

Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

International Breast Cancer Research Foundation

Phase 3 Completed
740 enrolled 14 charts
Breast

Breast Neoplasms

NCT00002580 2013-11-06

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer

National Cancer Institute (NCI)

Phase 3 Completed
1,000 enrolled
Breast

Breast Neoplasms

NCT00002582 2013-08-02

Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer

National Cancer Institute (NCI)

Phase 3 Completed
6,000 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡